HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Internationl PLC
Previous close
$38.54
Day range
$38.22 - $39.66
Year range
$17.82 - $41.28
Market cap
2.97B USD
Avg Volume
525.65K
P/E ratio
87.40
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 180.86M | 61.17% |
Operating expense | 73.27M | 1.12% |
Net income | 18.44M | 245.24% |
Net profit margin | 10.19 | 190.10% |
Earnings per share | 0.23 | 227.78% |
EBITDA | 24.40M | 363.58% |
Effective tax rate | 32.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 352.10M | 57.34% |
Total assets | 712.33M | 28.28% |
Total liabilities | 176.95M | 49.59% |
Total equity | 535.38M | — |
Shares outstanding | 75.80M | — |
Price to book | 5.43 | — |
Return on assets | 8.74% | — |
Return on capital | 11.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 18.44M | 245.24% |
Cash from operations | 33.68M | 1,606.13% |
Cash from investing | -62.76M | -888.58% |
Cash from financing | 11.90M | 77.89% |
Net change in cash | -17.18M | -806.54% |
Free cash flow | 19.56M | 126.18% |
About
Founded
2015
Website
Employees
315
